awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q24608005-05BDED0A-87DF-43CA-9850-8EEFAB108BDA
Q24608005-05BDED0A-87DF-43CA-9850-8EEFAB108BDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24608005-05BDED0A-87DF-43CA-9850-8EEFAB108BDA
Modes of resistance to anti-angiogenic therapy
P2860
Q24608005-05BDED0A-87DF-43CA-9850-8EEFAB108BDA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24608005-05BDED0A-87DF-43CA-9850-8EEFAB108BDA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b505feadb8d2f76cc91b3a7be905e10dcce765d0
P2860
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors